U.S. markets close in 3 hours 19 minutes

NeoGenomics, Inc. (NEO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
51.85-1.32 (-2.49%)
As of 12:41PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close53.17
Open53.59
Bid51.91 x 1100
Ask52.08 x 800
Day's Range51.62 - 53.66
52 Week Range20.47 - 61.57
Volume511,068
Avg. Volume901,865
Market Cap5.968B
Beta (5Y Monthly)0.72
PE Ratio (TTM)1,364.34
EPS (TTM)0.04
Earnings DateApr 26, 2021 - Apr 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est64.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-26% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ACCESSWIRE

    NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference

    MYERS, FL / ACCESSWIRE / March 1, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Chief Financial Officer Kathryn McKenzie and Doug Brown, Chief Strategy and Corporate Development Officer will be presenting at the Virtual Raymond James 42nd Annual Institutional Investors Conference 2021, on Wednesday, March 3, 2021 at 10:50am ET.

  • ACCESSWIRE

    NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference

    MYERS, FL / ACCESSWIRE / February 25, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Douglas VanOort, Chairman and Chief Executive Officer, Kathryn McKenzie, Chief Financial Officer and Doug Brown, Chief Strategy and Corporate Development Officer will be presenting at the Virtual 10th Annual SVB Leerink Global Healthcare Conference 2021, on Friday, February 26, 2021 at 10:00 am ET.

  • Neogenomics Inc (NEO) Q4 2020 Earnings Call Transcript
    Motley Fool

    Neogenomics Inc (NEO) Q4 2020 Earnings Call Transcript

    Image source: The Motley Fool. Neogenomics Inc (NASDAQ: NEO)Q4 2020 Earnings CallFeb 24, 2021, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, ladies and gentlemen, and welcome to the NeoGenomics Quarter Four and Full Year 2020 Earnings Call.